{"entity":{"type":"insider","cik":"0001840076","url":"/insider/0001840076","json_url":"/insider/0001840076.json","name":"Miles Darrin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":2,"first":"2021-03-16","last":"2021-05-18","span_basis":"filed_date"},"name_variants":[{"name":"Miles Darrin","source":"filing","n_filings":2,"first_seen":"2021-03-16","last_seen":"2021-05-18"}],"transactions":[{"id":4546222,"accession":"0001439222-21-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-21-000041","line_url":"/filing/0001439222-21-000041#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001840076","owner_name":"Miles Darrin","owner_url":"/insider/0001840076","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3462.0,"shares_display":"3,462","price_per_share":55.41,"price_display":"55.41","price_state":"stated","total_value":191829.42,"total_display":"191,829.42","shares_owned_after":7209.0,"shares_owned_after_display":"7,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-14","filed_date":"2021-05-18","scope":"insider"},{"id":4634139,"accession":"0001439222-21-000031","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-21-000031","line_url":"/filing/0001439222-21-000031#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001840076","owner_name":"Miles Darrin","owner_url":"/insider/0001840076","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":48.58,"price_display":"48.58","price_state":"stated","total_value":24290.0,"total_display":"24,290.00","shares_owned_after":10671.0,"shares_owned_after_display":"10,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-16","scope":"insider"},{"id":4634133,"accession":"0001439222-21-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-21-000031","line_url":"/filing/0001439222-21-000031#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001840076","owner_name":"Miles Darrin","owner_url":"/insider/0001840076","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":47.99,"price_display":"47.99","price_state":"stated","total_value":105578.0,"total_display":"105,578.00","shares_owned_after":11171.0,"shares_owned_after_display":"11,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-16","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001439222","name":"AGIOS PHARMACEUTICALS, INC.","url":"/issuer/0001439222","role":"Officer (Chief Commercial Officer)","n_filings":2,"first_seen":"2021-03-16","last_seen":"2021-05-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001840076","retrieved_at":"2026-08-22T03:59:52+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}